Credit: Getty Images Experts weigh in on the ramifications of GLP-1 drug shortages and how they affect patients who need ...

In the current study, patients with rheumatoid arthritis achieved a 59.4% success rate with methotrexate monotherapy. Patients with rheumatoid arthritis (RA) achieved a 59.4% success rate with ...

GLP-1 RAs can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight.

Vaginoplasty is associated with a high incidence of postoperative UTI and SSI, as well as significant gaps in HIV screening and PrEP prescribing.

Obesity is associated with self-reported symptoms of depression, eating disorders, and/or binge eating among treatment-seeking adolescents.

The FDA has issued a warning regarding compounded drugs distributed by Fullerton Wellness, LLC, in Ontario, California.

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women.

HealthDay News — Doctors in New York City are chronicling the first known U.S. cases of sexually transmitted ringworm ( Trichophyton mentagrophytes ).

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

FSH levels were independently associated with an increased risk for hip fracture among older men and women regardless of bone density.

Sotagliflozin is an oral dual sodium-glucose co-transporter types 1 and 2 (SGLT1/SGLT2) inhibitor. The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and ...